Presage, Celgene ally to identify new drug combos for solid tumor

Presage Biosciences and Celgene entered into a research alliance to find new drug combinations for solid tumors. Presage will get $5 million upfront, $8 million in equity investment plus potential future payments.

View Full Article in:

American City Business Journals · Genetic Engineering & Biotechnology News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Vice President, Idaho Regional Director
PacificSource
Boise, ID